Hematopoietic stem cell transplantation in children with sickle cell anemia: The parents' experience

Pediatric Transplantation
Raphaël CavadiniOlivier Taïeb

Abstract

Genoidentical HSCT is currently the only curative treatment for SCA, preventing further vascular complications in high-risk children. Studies on the psychological implications of HSCT for recipient, sibling donor, and the rest of the family have been limited in SCA. This study enrolled ten families and used semi-structured interviews to explore the parents' experience at three time points: first before transplantation, then 3 months later, and 1 year later. Three themes emerged from the results: (a) the presence of anxiety, experienced throughout the process, and alleviated by coping strategies (positive thinking, family support, praying); (b) the ability to remain parents to recipient and other family members, despite apprehension and feelings of helplessness, reinforced by the mobilization of important resources at the individual/family levels; (c) the ability to acknowledge the opportunity for their child to be cured of the disease, despite feelings of guilt toward families without a donor, or their own families back home. Overall, the parental experience with HSCT is complex, involving intra-psychic, familial, cultural, religious, and existential factors. Thus, it is important for medical teams to be cognizant of these issu...Continue Reading

References

Jan 1, 1990·Image--the Journal of Nursing Scholarship·C Vernale, S A Packard
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A MeyersD Przepiorka
Aug 1, 1997·Journal of Developmental and Behavioral Pediatrics : JDBP·W L PackmanM J Cowan
Apr 19, 2003·Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing·Sheila Judge Santacroce
May 26, 2004·Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community·Ulla Forinder
May 10, 2005·British Journal of Haematology·Paul WoodardJohn M Cunningham
Mar 27, 2009·Journal of Developmental and Behavioral Pediatrics : JDBP·Lisa Jobe-ShieldsSean Phipps
Feb 15, 2011·Pediatric Blood & Cancer·Sian CottonMeghan E McGrady
Dec 24, 2011·The Journal of Pediatrics·Vicky L NgUNKNOWN Studies of Pediatric Liver Transplantation (SPLIT) Research Group
Nov 29, 2012·Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]·Laurel WilliamsKaren Smith
Apr 19, 2015·Health and Quality of Life Outcomes·Katherine E HeinzeSusan K Parsons
Nov 28, 2017·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Zeynep Kisecik Sengul, Naime Altay
Jan 31, 2018·Palliative & Supportive Care·Christina MangurianJulia Kearney
Jun 10, 2018·British Journal of Health Psychology·Joanne MiddletonFiona Ulph

❮ Previous
Next ❯

Citations

Sep 7, 2019·Current Opinion in Hematology·Ahmed Galal, Mona Asslan
Feb 1, 2021·Journal of Pediatric Psychology·Marie L ChardonAhna L H Pai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.